BERLIN — U.S. pharmaceutical distributor McKesson Corp. has launched an $8.3 billion takeover offer for German competitor Celesio AG.
McKesson signed an agreement Thursday with German company Haniel to acquire its 50.01 percent stake in Celesio and is making an offer to other shareholders at $31.74 a share. The offer represents a 5.8 percent premium to Celesio’s closing share price on Wednesday.
San Francisco-based McKesson is also assuming Celesio’s debt, lifting the value of the deal up to $8.3 billion.
Guidelines: Please keep your comments smart and civil. Don't attack other readers personally, and keep your language decent. Comments that violate these standards, or our privacy statement or visitor's agreement, are subject to being removed and commenters are subject to being banned. To post comments, you must be a registered user on toledoblade.com. To find out more, please visit the FAQ.